Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Novartis Ag
Relationship:   10% Owner
City:   Basel Switzerland
State:   V8
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   49,437,478    

Indirect Shares

   22,159,174      
Direct Value   $481,385,768    

Indirect Value

   $313,535,707      
Total Shares   71,596,652      
Total Value   $794,921,475      


Adhera Therapeutics, Inc $0 Eledon Pharmaceuticals Ord Shs $11,593,122 Kineta Ord Shs $890,051 Aeglea Biotherapeutics, Inc. $1,306,711 Intellia Therapeutics, Inc. $91,270,856 Q32 Bio Inc $54,131,831 Ra Pharmaceuticals, Inc. $105,728,421 Surface Oncology, Inc. $4,224,876 Aileron Therapeutics Inc $6,674,855 Bicycle Therapeutics Ltd $0 Galera Therapeutics, Inc. $567,631 Poseida Therapeutics, Inc. $17,133,458 Cellular Biomedicine Group Inc $28,800,576 Precision Biosciences Inc $159,063,381 Adhera Therapeutics, Inc $0 Eledon Pharmaceuticals Ord Shs $11,593,122 Kineta Ord Shs $890,051 Aeglea Biotherapeutics, Inc. $1,306,711 Intellia Therapeutics, Inc. $91,270,856 Q32 Bio Inc $54,131,831 Ra Pharmaceuticals, Inc. $105,728,421 Surface Oncology, Inc. $4,224,876 Aileron Therapeutics Inc $6,674,855 Bicycle Therapeutics Ltd $0 Galera Therapeutics, Inc. $567,631 Poseida Therapeutics, Inc. $17,133,458 Cellular Biomedicine Group Inc $28,800,576 Precision Biosciences Inc $159,063,381
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    14    

     Stock price went up :
    0   
    14    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   14.0   
     Percentage Gain/Loss :
     0.0%
 273.2%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Momenta Pharmaceuticals Inc MNTA 10% Owner 0 2006-07-25 4,708,679    Premium*  
            Adhera Therapeutics, Inc ATRX 10% Owner 2011-01-26 2,495,065 0    Premium*  
            Idenix Pharmaceuticals Inc IDIX 10% Owner 2014-08-05 0 2014-08-05 0    Premium*  
            Eledon Pharmaceuticals Ord Shs ELDN 10% Owner 2015-07-15 4,493,458 2014-09-22 0    Premium*  
            Kineta Ord Shs KA 10% Owner 2016-02-17 1,873,791 2016-02-17 0    Premium*  
            Aeglea Biotherapeutics, Inc. AGLE 2018-05-11 2,175,314 2016-04-12 0    Premium*  
            Intellia Therapeutics, Inc. NTLA 10% Owner 2017-12-12 4,129,903 2016-05-11 0    Premium*  
            Q32 Bio Inc QTTB 10% Owner 2018-04-02 1,979,226 2018-04-02 0    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2017-06-19 2,251,457 2016-10-31 0    Premium*  
            Aadi Bioscience, Inc AADI 10% Owner 2017-03-15 0 2019-04-26 4,049,804    Premium*  
            Altimmune, Inc ALT 10% Owner 0 2018-09-12 8,345,145    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 3,948,482 2018-04-23 0    Premium*  
            Aileron Therapeutics Inc ALRN 10% Owner 2019-04-01 2,079,394 2018-07-16 0    Premium*  
            Bicycle Therapeutics Ltd BCYC 10% Owner 2019-05-28 1,769,641 2019-05-28 0    Premium*  
            Galera Therapeutics, Inc. GRTX Former 10% Owner 2020-06-19 2,467,961 2019-11-12 3,543,067    Premium*  
            Forma Therapeutics Holdings, Inc., FMTX 10% Owner 0 2020-06-18 331,221    Premium*  
            Akouos, Inc. AKUS Former 10% Owner 2020-06-30 0 2020-06-30 1,181,258    Premium*  
            Poseida Therapeutics, Inc. PSTX 10% Owner 2020-07-14 5,908,089 2020-07-14 0    Premium*  
            Cellular Biomedicine Group Inc CBMG 10% Owner 2020-08-11 1,458,257 0    Premium*  
            Precision Biosciences Inc DTIL 10% Owner 2022-06-15 12,407,440 0    Premium*  
* Premium Members only  

Records found :    152         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-02-28 4 S $20.86 $163,670 D/D (7,847) 2,468,815 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2018-07-26 4 S $3.63 $28,811 D/D (7,937) 2,479,685 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2018-08-01 4 S $3.22 $26,343 D/D (8,181) 2,458,546 0 -
GRTX Galera Therapeutics, Inc. 10% Owner   –       –       •   2020-06-10 4 S $9.46 $80,713 D/D (8,532) 3,498,259 0 %
GRTX Galera Therapeutics, Inc. 10% Owner   –       –       •   2020-06-16 4 S $9.30 $79,980 D/D (8,600) 3,474,795 0 %
GRTX Galera Therapeutics, Inc. 10% Owner   –       –       •   2020-06-05 4 S $9.66 $83,578 D/D (8,652) 3,519,450 0 %
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2018-08-17 4 S $2.10 $18,270 D/D (8,700) 2,417,270 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2018-08-16 4 S $2.10 $18,497 D/D (8,808) 2,425,970 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-05-18 4 S $25.50 $229,964 D/D (9,019) 2,409,403 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-01 4 S $23.89 $256,176 D/D (10,722) 2,340,338 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2018-07-25 4 S $3.84 $47,846 D/D (12,460) 2,487,622 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2018-07-17 4 S $4.71 $58,875 D/D (12,500) 2,531,382 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2019-03-14 4 S $1.88 $25,944 D/D (13,800) 2,250,344 0 -
ALT Altimmune, Inc 10% Owner   –       –       •   2018-06-15 4 A $0.00 $0 I/I 14,449 5,611,806 0 -
ELDN Eledon Pharmaceuticals Or... 10% Owner   –       –       •   2014-06-15 4 S $14.20 $209,833 D/D (14,777) 4,546,616 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-06-02 4 S $23.47 $348,949 D/D (14,867) 2,325,471 0 -
AGLE Aeglea Biotherapeutics, I...   •       •       •   2018-05-07 4 S $10.11 $157,190 D/D (15,548) 2,295,376 0 -
AADI Aadi Bioscience, Inc 10% Owner   –       –       •   2019-04-24 4 S $1.03 $16,895 I/I (16,403) 4,751,604 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-05-24 4 S $25.01 $436,364 D/D (17,451) 2,391,952 0 -
AGLE Aeglea Biotherapeutics, I...   •       •       •   2018-05-11 4 S $10.06 $196,673 D/D (19,550) 2,175,314 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-05-16 4 S $26.33 $528,725 D/D (20,081) 2,440,956 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2018-08-20 4 S $2.30 $46,892 D/D (20,388) 2,396,882 0 -
ALRN Aileron Therapeutics Inc 10% Owner   –       –       •   2019-04-01 4 S $1.90 $39,159 D/D (20,610) 2,079,394 0 -
ELDN Eledon Pharmaceuticals Or... 10% Owner   –       –       •   2015-07-13 4 S $14.20 $292,717 D/D (20,611) 4,524,885 0 -
RARX Ra Pharmaceuticals, Inc. 10% Owner   –       –       •   2017-05-17 4 S $25.51 $574,901 D/D (22,534) 2,418,422 0 -
  152  Records found
  1   2   3  4   5   6   7      
  Page 3 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us